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DESIGN AND FABRICATION OF MULTIPURPOSE SMART PHANTOM  
FOR POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY 
IMAGING 
 
ABSTRACT 
 
Phantom studies are an important part in medical imaging as it can evaluate the 
performance and quality assurance (QA) test of dual-modality PET/CT. The purpose of 
this study is to design, fabricate and develop a multipurpose smart phantom which 
includes the internal structures, water, human tissue equivalent materials and radioactive 
source for dual-modality Positron Emission Tomography/Computed Tomography 
(PET/CT) imaging. In this study, experimental determination of Hounsfield units (HU), 
mass attenuation coefficient, elemental composition analysis and structure analysis were 
performed on phantom materials using PET/CT scanner, Multichannel Analyser (MCA), 
CHNS analyser and Scanning Electron Microscope/Energy Dispersive X-Ray 
(SEM/EDX) respectively. From these analyses, the fabricated inserts of epoxy, 
polyurethane and paraffin wax were found to be equivalent to human spongy bone, lung 
and soft tissue respectively. The CT numbers of these inserts were +220.094 HU,             
-949.725 HU and -115.499 HU respectively. Besides, other properties of these phantom 
materials had been identified and were compared with human tissues. These fabricated 
inserts together with PMMA and PTFE were then selected for the designed and 
fabrication of a multipurpose smart phantom. PET/CT performance tests carried out on 
the phantom demonstrated that the fabricated phantom can be utilised as a phantom for 
PET/CT imaging for various types of human tissues.  
xxix 
 
REKABENTUK DAN FABRIKASI FANTOM PINTAR PELBAGAI TUJUAN 
UNTUK PENGIMEJAN TOMOGRAFI PANCARAN POSITRON/ 
TOMOGRAFI BERKOMPUTER  
 
ABSTRAK 
Kajian fantom adalah bahagian yang penting dalam pengimejan perubatan kerana ia 
dapat menilai perlaksanaan dan ujian jaminan kualiti (QA) dwi-modaliti Tomografi 
Pancaran Positron/Tomografi Berkomputer (PET/CT). Tujuan kajian ini adalah untuk 
merekabentuk, memfabrikasi dan membangunkan fantom pintar pelbagai tujuan yang 
termasuk struktur dalaman, air, bahan-bahan setara dengan tisu manusia dan sumber 
radioaktif untuk pengimejan dwi-modaliti PET/CT. Dalam kajian ini, penentuan secara 
eksperimen Unit Hounsfield (HU), pekali atenuasi jisim, analisis komposisi elemen dan 
analisis struktur telah dilakukan terhadap bahan-bahan fantom menggunakan PET/CT 
skan, Penganalisis Berbilang Saluran (MCA), Penganalis CHNS dan Pengimbas 
Mikroskop Elektron/Keselerakan Tenaga X-ray (SEM/EDX) masing-masing.     
Daripada analisis ini, fabrikasi epoksi, poliuretin dan lilin paraffin didapati             
masing-masing setara dengan tulang lembut manusia, paru-paru dan tisu lembut. 
Nombor-nombor CT bahan-bahan ini adalah +220.094 HU, -949.725 HU dan                   
-115.499 HU masing-masing. Selain itu, ciri-ciri lain bahan-bahan ini juga dikenalpasti 
dan dibandingkan dengan tisu manusia. Bahan-bahan yang difabrikasi ini bersama 
dengan PMMA dan PTFE kemudian telah dipilih untuk rekabentuk dan fabrikasi fantom 
pintar pelbagai tujuan. Ujian perlaksanaan PET/CT yang dijalankan ke atas fantom 
menunjukkan bahawa fantom yang difabrikasi boleh dimanfaatkan sebagai fantom untuk 
pengimejan PET/CT bagi pelbagai jenis tisu manusia. 
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CHAPTER 1: INTRODUCTION 
 
1.1 BACKGROUND 
Medical imaging of the human body requires some form of energy. In the medical 
imaging techniques used in radiology, the energy used to produce the image must be 
capable of penetrating tissues. The electromagnetic spectrum outside the visible light 
region is used for X-ray imaging, including mammography, Computed Tomography 
(CT), magnetic resonance imaging (MRI) and in nuclear medicine. Mechanical energy 
in the form of high-frequency sound waves is used in ultrasound imaging. The advances 
in medical imaging and computerised medical image processing have led to new            
two-dimensional (2D) and three-dimensional (3D) imaging modalities that have become 
important clinical tools in diagnostic radiology. The clinical significance of radiological 
imaging modalities in diagnosis and treatment of diseases is overwhelming.  
 
Several modern imaging modalities are in practice today to acquire anatomical, 
physiological, metabolic and functional information from the human body. The 
commonly used medical imaging modalities capable of producing multidimensional 
images from radiological diagnostic applications are: X-ray CT, Single Positron 
Emission Tomography (SPECT), Positron Emission Tomography (PET) and ultrasound. 
These modern imaging methods involved sophisticated instrumentations and equipments 
using high-speed electronics and computers for data collection, image reconstruction and 
display. The recent complex medical imaging modalities depend heavily on computer 
technology for creation and display of digital images.  
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Using computers, multidimensional digital images of physiological structures can be 
processed and manipulated to visualise hidden characteristic diagnostic features that are 
difficult or impossible to see with planar imaging methods. Furthermore, these features 
of interest can be quantified and analysed using sophisticated computer programs and 
models to understand their behavior to help with a diagnosis or to evaluate treatment 
protocols. Imaging methods available today for radiological applications may use 
external, internal or a combination of energy sources. In most commonly used imaging 
methods, ionised radiation imaging such as X-rays are used as an external energy source 
primarily for anatomical imaging. Such anatomical imaging modalities are based on 
attenuation coefficient of radiation passing through the body.  
 
For example, X-ray radiographs and CT imaging modalities measure attenuation 
coefficients of X-ray that are based on density of the tissue or part of the body being 
imaged. Another example of external energy source based imaging is ultrasound or 
acoustic imaging. With the exception of nuclear medicine, all medical imaging requires 
that the energy used to penetrate the human body’s tissue also interact with those tissues. 
If energy were to pass through the body and some type of interaction such as absorption, 
attenuation and scattering occurs, then the detected energy would contain useful 
information regarding the internal anatomy and thus it would be possible to construct an 
image of the anatomy using that information. In nuclear medicine imaging, radioactive 
agent is injected or ingested and it is metabolic or physiologic information of the agent 
that gives rise to the information in the images. 
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This imaging modalities use an internal energy source through an emission process to 
image the human body. For emission imaging, the injected radioactive pharmaceuticals 
are interacting with selected body matter or tissue to form an internal source of 
radioactive energy that is used for imaging. The emission process and energy range of   
γ-rays cause limitations on the resolution and data acquisition time for imaging. This 
emission imaging principle is applied in PET and SPECT. Such types of nuclear 
medicine modalities provide useful metabolic information about the physiological 
functions of the organ. Further, a good combination of external stimulation on internal 
energy sources can be used in medical imaging to acquire more accurate information 
about the tissue material and physiological responses and functions.  
 
In recent years, technological advances enabled the development of a new scanner that 
combines PET and CT into one machine. The result is an entirely new picture in the 
science of diagnostic imaging providing a far more complete picture of a patient's 
overall health. Positron Emission Tomography/Computed Tomography (PET/CT) is 
unique imaging technologies that visualise abnormalities within the body. Each yields 
very different information and the two modalities have been used in conjunction in the 
diagnosis, treatment and follow-up of cancer. Unlike conventional imaging procedures 
that measure the structure of an abnormality, PET measures the metabolic changes that 
occur in cells when disease is present. The atoms, molecules and cells of our body have 
particular behaviors and chemical processes. At the onset of disease, these behaviors 
change, often before a detectable physical difference like a tumor occurs. This is because 
cancer cells behave differently than normal cells. PET technology can detect these subtle 
changes and identify cancer at its most basic cellular level.  
4 
 
On the other hand, PET is limited in that it does not give the size or shape of the 
abnormality. Thus, CT scan procedures will perform this task. It combines X-ray 
technology with advanced computer acquisition to uncover the precise form and location 
of an abnormality. CT is one of the primary tools of measurement in oncology 
evaluation. It is extremely fast and yields minutely thin slices, cross-sectional views of 
the body. The new PET/CT scanner acquires both pictures during the same exam. 
Sophisticated software then fuses the images. The result is a full body view showing the 
presence or absence of disease, how active it is, whether or not it is spread and precisely 
where and how large an abnormality is. In addition to diagnosis and staging, the PET/CT 
scan is essential in re-staging or detecting remaining cancer cells after the patients had 
undergone treatment. Besides, the PET/CT imaging also performs one image which 
shows all the organ systems and it can shows how the body respond to treatment.   
 
A safe, short-lived radiopharmaceutical, known as 18F-fluorodeoxyglucose (18F-FDG) is 
used in PET/CT scan studies. This is related to the high standardisation and relative ease 
of synthesis of this tracer, to the relatively long half-life of 18F which allows distribution 
of FDG in human body and to its well known biological behaviour. 18F-FDG is tagged to 
a glucose molecule because cancer cells are highly metabolic and use more glucose than 
normal cells, hence the increased glucose activity is measured. Mostly, 18F-FDG is 
supplied in isotonic saline as a sterile, non-pyrogenic, clear, colourless solution and it is 
used for diagnostic radiopharmaceutical for PET. The calculated activity is related to 
Standardised Uptake Value (SUV) and is reported as an absolute number.  
 
5 
 
It is now considered the most accurate clinical staging study for non-small-cell lung 
cancer and is also important in the staging of other multiple malignancies                
(Black, Quinten C. et al., 2004). 18F-FDG decays by positron emission and has a half life 
of 110 minutes. The principal photons useful for diagnostic imaging are the 511 keV 
gamma photons, resulting from the interaction of the emitted positron with an electron. 
This radiopharmaceutical had been injected into the phantom to evaluate PET image 
quality which includes ROI analysis, SUV analysis and so on. American College 
Accreditation (ACR) had provided an instruction for PET phantom for routine 
evaluation of PET/CT systems.  
 
Phantom is a tissue substitute of any material that simulates a body of tissue in its 
interaction with ionising or non-ionising radiation. It can be any structure that contains 
one or more tissue substitutes and in the case of radiographic phantom, it is used to 
simulate radiation interactions in the human body. A phantom allows the effects of an 
imaging system on receptor quantification to be investigated under conditions very 
similar to those in a patient. It can be used to optimise the imaging system for patient 
imaging and to examine information about the procedure such as estimated dosage 
given. Phantom studies are used to perform numerous tasks and an important part in 
diagnostic imaging quality as it can evaluates the performance and quality assurance 
(QA) test of imaging modalities. Besides, phantoms are often used to demonstrate the 
relationship between objects scanned and their final images. 
 
Water tanks were often used for X-ray experiments and till now these materials are still 
in use in certain applications. Currently, the use of tissue equivalent materials has 
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increased over the years. There are a number of material substitutes which is equivalent 
to tissues of human organs or body parts such as polyester (Brain W. et al., 2006), 
polystyrene (Joel Y. C. Cheung et al., 2002), polyethylene (Jessi Clements et al., 2002), 
epoxy resin (Jessi Clements et al., 2002; Brain W. et al., 2006) and polymethyl 
methacrylate (PMMA) (Joel Y. C. Cheung et al., 2002; Parodia K et al., 2007).           
Much research has been carried out to find the most suitable tissue equivalent material in 
diagnostic radiology (Christopher J. Bachler et al., 2006), radiotherapy                   
(Lavely et al., 2004) and radiation protection (G. Dietze, 2000; J. I. Kim et al., 2006).  
 
Since phantoms are designed to mimic tissue, they are typically composed of materials 
that act like tissue. Ideally, the phantom material substitutes must have the same density 
and the same mass attenuation coefficient properties with those of human tissues being 
simulated. The mass attenuation coefficient is a measure that describes how much 
radiation will attenuate in a material and it is dependent on the density of the absorbing 
material. In PET/CT imaging, phantom study plays an essential part in medical imaging 
as this dual purpose imaging device can shows the metabolic or chemical activity in the 
body and the anatomical structures of human body. The individual scans, which are 
taken virtually consecutively, can be presented separately or as a single, overlapping or 
fused image. 
 
 Quality control (QC) of CT consists of imaging a phantom and checking for CT 
number. This QC need to make sure that the CT numbers are accurately calibrated. The 
energy calibration on the CT scanner at 120 kVp, 100 kVp, or 140 kVp will generate the 
attenuation maps that are used for PET purposes. Besides, for PET side the QC of it is 
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performed, the activity injected, time and issues such as that are need to be considered in 
order to improve diagnostic accuracy in common cancers. The ability to do PET imaging 
allows us to identify cancer cells, if they are present, more accurately over the traditional 
methods such as CT which are dependent on imaging the anatomy. So PET essentially 
visualise metabolism and function. Consequently, this study can be done on phantom 
which will overcome some of the problems encountered in QC tests and it gives more 
information about the result acquired from the medical imaging modalities. 
 
1.2 RESEARCH PROBLEM 
At present, there are a number of commercially available PET/CT test phantoms for 
measuring daily QC tests and periodic, comprehensive QC testing to meet the 
requirements of the Food and Drug Administration (FDA), United States. In any case, 
test phantoms are often considered difficult, tedious or requiring special software, in 
addition to cost-effectiveness problems. Previously, the available existing phantom is 
simplistic with only few tissue equivalent materials, usually made of 
polytetrafluoroethylene (PTFE), air, water and it is limited to certain tissues equivalent 
only.  
 
Although PET/CT imaging offers many advantages, this dual-modality imaging also 
possesses some challenges. The interpretation of PET/CT images is very important to 
make use of the available data, and at very least, provide an interpretation of the precise 
location and anatomical relationships of 18F-FDG abnormalities                       
(Wechalekar K. et al., 2005). These reasons have been the force behind the efforts to 
develop a practical, handy and cheap phantom.  
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On the same note, there is an urgent need to study phantoms to evaluate the image 
quality in whole-body PET/CT imaging. Consequently, to design a new test phantom 
that would combine simplicity with quality to facilitate the evaluation of PET/CT 
systems.  
 
1.3 OBJECTIVES OF RESEARCH 
The main objectives of this research can be summarised as follows: 
1. To design, fabricate and develop a multipurpose smart phantom which includes 
the internal structures, water, human tissue equivalent materials and radioactive 
source for PET/CT imaging. 
2. To analyse the properties of manufactured and fabricated phantoms materials and 
comparison with human tissues. 
3. To study the PET/CT performance tests using fabricated multipurpose smart 
phantom. 
 
1.4 SCOPE OF RESEARCH 
In this study, suitable existing and new fabricated materials will be identified to test for 
suitability as tissue equivalent materials for PET/CT imaging. The phantom will be 
designed and fabricated using the identified materials which are equivalent to human 
tissues with appropriate CT numbers. Furthermore, a radioactive source will be inserted 
in this phantom to evaluate the PET/CT performance test on the multipurpose smart 
phantom.  
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1.5 THESIS ORGANISATION 
In this section, the contents of the successive chapters will be described. In Chapter 2, 
the discussion will focus on fundamentals of interaction of radiation with matters. 
Besides, it also reviews the current research relevant to this study. In Chapter 3,                
a description of equipments that have been used in this research will be presented.  
 
Next, the methodology of this study will be discussed in Chapter 4. In this chapter,              
the discussion will focus on preparation of phantom materials, tests for manufactured 
and fabricated phantom materials, fabrication of new phantoms and PET/CT 
performance tests. Besides, in Chapter 5 the discussion will focus on results and 
discussions which include the results obtained from phantom materials tests, analysis of 
selected phantom materials and results of PET/CT performance test. 
 
Last but not least, the conclusion and further work will be summarised in Chapter 6. 
Finally, it will be followed by references, appendices and list of publications. 
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CHAPTER 2: THEORY AND LITERATURE REVIEW 
 
2.1 FUNDAMENTALS OF INTERACTION OF RADIATION WITH 
 MATTER 
High-energy photons (gamma rays, X-rays, annihilation radiation and Bremsstrahlung) 
transfer their energy to matter in complex interactions with atoms, nuclei and electrons. 
However, these interactions can be viewed as a simple collision between a photon and a 
target atom, nucleus or electron. These interactions do not cause ionisation directly, as 
do the charged particle interactions. Some of the photons interactions result in the 
injection of orbital electrons from atoms or in the creation of positive-negative electron 
pairs. These electrons in turn cause ionisation effects, which are the basis for 
mechanisms by which high-energy photons are detected and by which they cause 
radiobiologic effects. For these reasons, high-energy photons are classified as secondary 
ionising radiation. The selective interactions of X-ray photons with the structure of the 
human body produces the image; the interaction of photons with the receptor converts an 
X-rays or gamma rays image into one that can be viewed or recorded.  
 
There are five types of interactions with matter by X-ray and gamma ray photons; 
Compton effect, photoelectric effect, pair production, Rayleigh (coherent) scattering and 
photonuclear interactions. The first three of these are the most important, as they result 
in the transfer of energy to electrons, which then impart that energy to matter in many 
(usually small) Coulomb-force interactions along their tracks. The relative importance of 
Compton effect, photoelectric effect and pair production depends on both the photon 
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quantum energy and the atomic number, Z of the absorbing medium as shown in         
Eq. 2.1, 2.2 and 2.3.  
 
    σ   ∞   electron density 
    ρ                  E 
Where: σ/ ρ   = Mass attenuation coefficient of Compton process 
  E      = Energy    
 
 
     τ   ∞  Z3 
     ρ       E3 
 
Where:  τ/ ρ   = Mass attenuation coefficient of photoelectric process 
  Z       = Atomic number 
  E      = Energy           
 
     π   ∞  (E – 1.02) Z 
     ρ 
Where: π/ ρ   = Mass attenuation coefficient of pair production process 
   E     = Energy   
  Z      = Atomic number 
 
2.1.1 PHOTOELECTRIC PROCESS 
In this process, an incident photon striking an atom ejects one of the orbital electrons of 
the atom (Figure 2.1). During this absorption the gamma ray disappears, its entire energy 
being given up.  
 
 
       
 
 
 
Photoelectron 
Figure 2.1 Schematic representation of the photoelectric effect. 
(Taken from Sprawls Educational Foundation) 
2.1 
2.2 
2.3 
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The kinetic energy, Ke of the emitted photoelectron is shown in Eq. 2.4. The 
photoelectron could be emitted from the K-shell, L-shell, etc., of the atom. The 
photoelectric process will take place only if hν > EB. 
 
Ke = hν - EB 
Where:  Ke = Kinetic energy of the emitted photoelectron 
  h   = Planck constant 
  ν   = Velocity of the electron 
  EB = Binding energy of the emitted electron 
 
After the atomic electron is ejected by a photoelectric effect, the vacancy in that shell is 
filled up by another electron from the outer shell. This is followed by emission of X-rays 
or Auger electrons consuming the binding energy EB. The configuration of the atomic 
shell recovers within a very short time after the photoelectric emission. The atomic      
X-rays absorbed by the matter surrounding the point of emission, giving rise to further 
electrons. Thus the total energy of the incident gamma ray is completely converted into 
the kinetic energy of the electrons. The cross section for photoelectric effect has been 
calculated and it depends on hν and Z according to Eq. 2.5. 
 
σph   _Z5__ 
            (hν)7/2 
Where: σph = Cross section of photoelectric process 
  Z    = Atomic number 
  hν   = Quantum energy 
  
 
 
2.4 
2.5 
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2.1.2 COMPTON SCATTERING 
Compton scattering occurs when the incident X-ray photon interacts with a free electron 
and is scattered with a loss of energy. Compton scattering also includes scattering of 
photons by electrons bound to an atom because in comparison to the energy of the 
photon, the electron binding energy is quite small (Figure 2.2).  
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Schematic representation of Compton scattering. 
(Taken from Sprawls Educational Foundation) 
 
Thus, an incident photon of energy hν can be considered to collide with a free electron 
of rest mass m0. The photon is scattered through an angle θ with an energy hν’ (< hν) 
while the electron recoils with a kinetic energy Ke at an angle ø. Application of laws of 
conservation of linear momentum and energy with relativistic expressions gives the 
expressions as shown in Eq. 2.6.  
 
hν’ = _____hν______ 
         1 + α (1 – cos θ) 
 
Where:  hν = Photon energy 
  θ   = Electron angle  
 
 
Scattered X-ray 
Photoelectron 
2.6
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2.1.3 PAIR PRODUCTION 
Pair production is a direct conversion of radiant energy to matter. For pair production to 
occur, the electromagnetic energy, in a discrete quantity called a photon, must have 
energy greater than 1.02 MeV strikes a material of high Z, it is found that the photon is 
completely absorbed and a pair of electron and positron is produced (Figure 2.3).  
 
Figure 2.3 Kinematics of pair production process. 
(Taken from Sprawls Educational Foundation) 
 
The threshold energy of the photon is 1.02 MeV. The conversion of energy yields as 
shown in Eq. 2.7. The presence of the nucleus is essential for the conversion of linear 
momentum. 
 
hν = 2m0c2 + E+ + E- + Enuc 
where  hν  = The incident photon energy 
  2m0c2 = The rest mass of the electron-positron pair 
  E+ = The kinetic energy of positron 
  E+ = The kinetic energy of electron 
  Enuc =  The kinetic energy of nucleus 
 
 
 
2.7
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2.1.4 RAYLEIGH (COHERENT) SCATTERING 
Rayleigh scattering is called coherent because the photon is scattered by the combined 
action of the whole atom. The event is elastic in the sense that the photon loses 
essentially none of its energy; the atom moves just enough to conserve momentum. The 
photon is usually redirected through only a small angle.  
 
Therefore the effect on a photon beam can only be detected in narrow-beam geometry. 
Rayleigh scattering has more practical importance at low energies, partly because the 
scattering angle is greater. The relative importance of this process is seen to be fairly 
small, as it contributes only a few percent or less of the narrow-beam attenuation 
coefficient.  
 
2.1.5 PHOTONUCLEAR INTERACTIONS 
Photonuclear reactions are one of the methods for generating radionuclide.               
These reactions require minimum photon energy of about 2 MeV and they are not 
significant in most elements until photon energies exceed about 10 MeV. Also, even at 
these energies, the probability of photonuclear reactions is much smaller than that of 
Compton scattering or pair production. Furthermore, the effective total sum of 
attenuation coefficients is the total sum of attenuation coefficient of photoelectric 
absorption and Compton scattering. Therefore, photonuclear reactions are of no practical 
importance in terms of photon beam attenuation or the transfer of photon energy to 
matter. 
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2.2 ATTENUATION OF PHOTON BEAM 
When a photon passes through a thickness of absorber material, the probability that it 
will experience an interaction depends on its energy and on the composition and 
thickness of the absorber (Figure 2.4).  
 
 
 
 
 
 
 
Figure 2.4 Photon beam transmission. 
(Taken from Sprawls Educational Foundation)  
 
Consider a beam of photons of intensity I (photons/cm2.sec) directed onto an absorber of 
thickness ∆x. Due to composition and photon energy effects, it will be assumed for the 
moment that the absorber is comprised of a single element of atomic number, Z and that 
the beam is monoenergetic with energy E. A photon detector records transmitted beam 
intensity. The fractional decrease in beam intensity ∆I/I is related to absorber thickness 
∆x as shown in Eq. 2.8. The minus sign indicates beam intensity decreases with 
increasing absorber thickness.  
 
(∆I/I) = -µl∆x 
Where: ∆I = Transmitted photon beam intensity 
  I    = Incident photon beam intensity 
  µl   = Linear attenuation coefficient of the absorber 
  ∆x = The thickness of the absorber 
 
∆ x
Incident photon beam 
Absorber
Detector 
2.8
Transmitted photon 
beam
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The quantity of µl is found to increase linearly with absorber density ρ. Density effects 
are factored out by dividing µl by density ρ as shown in 2.9. The mass attenuation 
coefficient of the material has dimensions cm2/g. It depends on the Z of the absorber and 
photon energy E. The total mass attenuation coefficient for gamma ray interactions, 
neglecting photonuclear interactions can be written in units of cm2.g-1 as shown in         
Eq. 2.10.  
 
 
µm = µl/ ρ 
Where:  µm = Mass attenuation coefficient of the material 
   µl  = Linear attenuation coefficient of the material 
   ρ   = Density of the material 
 
µ    τ    σ   κ 
ρ     ρ   ρ    ρ 
 
Where: µ/ρ = Total mass attenuation coefficient for gamma ray interactions 
  τ/ρ  = Mass attenuation coefficient of photoelectric process 
  σ/ρ = Mass attenuation coefficient of Compton effect  
  κ/ρ = Mass attenuation coefficient of pair production 
 
 
2.3 DECAY OF RADIOACTIVITY 
Radioactivity decay is a spontaneous process; there is no way to predict uncertainty the 
exact moment at which an unstable nucleus will undergo its radioactive transformation 
into another, more stable nucleus. Radioactive decay is described in terms of 
probabilities and average decay rates.  
 
 
2.9
++ 2.10=
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2.3.1 DECAY CONSTANT 
The average decay rate of a sample containing N radioactive atoms of a certain 
radionuclide is as shown in Eq. 2.11. The decay constant has a characteristic value for 
each radionuclide. It is the fraction of the atoms in a sample of that radionuclide 
undergoing radioactive decay per unit of time during a time period that is so short that 
only a small fraction decay during that interval. The unit of λ is s-1. 
 
∆N / ∆t = - λ N 
Where:  ∆N = Numbers of atoms of the nuclide in the sample present at a 
       time, t 
  ∆t  =  Time  
  λ     =  Decay constant 
  N =  Number of atoms of the nuclide in the sample initially present 
 
2.3.2 DEFINITIONS AND UNITS OF ACTIVITY 
The quantity ∆N/∆t, the average decay rate is the activity A of the sample. It has 
dimensions decays per second (dps) or decays per minute (dpm) and is essentially a 
measure of how radioactive the sample is. The S.I unit of activity is Becquerel (Bq).        
The equation of activity for a sample is as shown in Eq. 2.12. 
 
A (Bq) = λ N 
Where: A = Activity of the nuclide (disintegrations/second) 
  λ  = Decay constant (s-1) 
  N = Number of atoms of the nuclide in the sample 
 
 
 
 
2.11 
 2.12 
19 
 
2.3.3 EXPONENTIAL DECAY 
With the passage of time, the number N of radioactive atoms in a sample decreases. 
Therefore, A of the sample also decreases. Figure 2.5 illustrates the radioactive decay 
with the passage of time.  
 
Figure 2.5 Decay of radioactive sample during successive 1 s increment of time.  
(Taken from Integrated Publishing’s Archive Service, 2007) 
 
The number of atoms remaining after a time, t is as shown in Eq. 2.13. Since A is 
proportional to N, the decay factor also supplies to activity versus time as shown in     
Eq. 2.14. 
 
N(t) = N0 e-λt 
Where: N(t) = Number of atoms at a time, t 
  N0    = Number of atoms initially present 
  λ      = Decay constant 
  t       = Time 
 
A(t) = A0 e-λt 
Where : A(t) = Activity present at time, t 
  A0    = Activity initially present 
  λ      = Decay constant 
  t       = Time 
2.13 
 2.14 
0 1 2 3 4
Decay time (s)
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2.3.4 RADIOACTIVITY HALF-LIFE 
One of the most useful terms for estimating how quickly a nuclide will decay is the 
radioactive half-life.  The radioactive half-life is defined as the amount of time required 
for the activity to decrease to 50% of its initial activity level. A relationship between the 
half-life and decay constant can be developed from Eq. 2.15.  
 
A(t) = A0 e-λt 
        ln    A     = -λt 
               A0 
 
t  = ln   A 
                                                                          _A0_  
                                                                             λ 
 
The half-life can be calculated by solving Eq. 2.14 for the time, t, when the current 
activity, A, equals one-half the initial activity A0. Substituting this in the Eq. 2.15 above 
yields an expression for t1/2 as shown in Eq. 2.16.    
 
t1/2  =  -  ln    1 
                                                                                 2__  
                                                                                  λ 
 
t1/2  =  ln 2  = 0.693 
                                                                     λ           λ                                                                              
 
 
Figure 2.6 shows radioactive decay as a function of time in units of half-life. An initial 
number of atoms N0, the population, and consequently, the activity may be noted to 
decrease by one-half of this value in a time of t1/2.  Additional decreases occur so that 
whenever t1/2 elapses; the number of atoms drops to one-half of what its value was at the 
2.15 
 2.16 
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beginning of that time interval. After five half-lives have elapsed, only 1/32, or 3.1%, of 
the original number of atoms remains. After seven half-lives, only 1/128, or 0.78%, of 
the atoms remains. The  number  of  atoms  existing  after  5  to  7  half-lives  can  
usually  be assumed   to   be   negligible.  
 
 
 
 
 
 
Figure 2.6 Radioactive decay as a function of time in units of half-life.  
(Taken from Integrated Publishing’s Archive Service, 2007) 
 
  
The lifetimes of individual radioactive atoms in a sample range anywhere from very 
short to very long. Some atoms decay almost immediately, whereas a few do not decay 
Time in units of half-life, t1/2 
Normalised concentration, N/N0 
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for relatively long time. The average lifetime τ of the atoms in a sample has a value that 
is characteristic of the nuclide and is related to the decay constant λ as shown in          
Eq. 2.17. 
 
τ = 1/ λ 
Where:  τ = Average lifetime 
  λ = Decay constant 
 
2.4 CT NUMBERS  
CT numbers is also known as Hounsfield units (HU). The reconstruction of algorithm 
generates CT numbers which are related to attenuation coefficients. The CT numbers 
range from -1000 HU for air to +1000 HU for bone, water and consequently each    
water-equivalent tissue with µT = µwater has the value 0 HU. For an arbitrary tissue T 
with attenuation coefficient µT  the CT values is defined as in Eq. 2.18 
 
H = (µT - µwater) / µwater x 1000 HU  
Where: H  = Hounsfield unit or CT number 
  µT  = Linear attenuation coefficient of tissue 
  µwater = Linear attenuation coefficient of water 
                   
An increase in CT values can be assigned to increased density or an increase in effective 
atomic number. This corresponds to the physical definition of the linear attenuation 
coefficient as shown in Eq. 2.19. 
 
µ = (µ / ρ) (E, Z). ρ 
Where: µ = Linear attenuation coefficient  
  ρ = Density  
  E = Energy 
  Z = Atomic number 
2.17 
  2.18 
  2.19 
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2.5 SUV OF 18F-FDG 
The most widely used semiquantitative index in PET studies is the SUV which 
represents an index for FDG accumulation in tissue. This can be calculated as the ratio 
between the FDG uptake (MBq/ml) in a small ROI (placed over the tumour in an 
attenuation-corrected image) and the administered activity to the weight (kg) or body 
surface (m2) of the patient.  The equation of SUV is as shown in Eq. 2.20.  
 
 SUV =       Tissue concentration (MBq/g) ____ 
        Injected dose (MBq) / body weight (g) 
 
A calibration factor is required to convert the value measured from the image into 
MBq/ml. SUVs should be calculated in the hottest part of the lesion because cancer 
tissues have a very heterogeneous distribution of FDG uptake. Calculation of the SUV 
requires all available data on patient characteristics (weight, height, blood glucose 
levels) and injected radiopharmaceutical (injected activity of FDG, preparation time and 
administration time).  
 
2.6 LITERATURE REVIEW 
2.6.1 Phantom 
Paul E. Kinahan et al. (2007) studied on a calibration phantom for multi-centre and 
longitudinal PET/CT studies of assessing response to therapy. The phantom is based on 
the National Electrical Manufacturers Association (NEMA) NU-2 IQ phantom, with six 
hot spheres (internal diameters of 10 mm, 13 mm, 17 mm, 22 mm, 28 mm, and 37 mm) 
as target lesions. The phantom uses Ge-68 to remove filling variability and allow for 
estimating standard errors and reproducibility. Absolute quantitation is obtained by 
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using a National Institute of Standards Technology (NIST) traceable source for the       
Ge-68 calibration phantom. The effect of lesion size is measured by the six spheres.     
The overall activity level is based on a 10-15 mCi injection in a 70 kg patient,            
with sphere:background ratio set to 4:1. The resulting images analysed in terms of mean 
and max absolute activity and SUV vary with sphere diameter. 
 
Ruiz-Trejo et al. (2005) concentrated on a study of design and construction of                
CT phantom. A phantom for performance evaluation and quality assurance of CT 
scanners was designed and built in agreement with quality control requirements 
established by the Mexican Regulations. Phantom materials were chosen after 
experimental determination of their Hounsfield units. The phantom allows performing 
the following tests: calibration, constancy and uniformity of the CT number. CT number 
dependence on the reconstruction algorithm, high and low contrast resolution, slice 
thickness and coincidence of the slice with the light system for patient alignment. Image 
quality assessment for CT exams was performed using a commercially two different CT 
scanners. 
 
C. B. Chiarot et al. (2005) studied on development, characterisation, and QA of 
advanced X-ray imaging technologies which require phantoms that are quantitative and 
well suited to such modalities. This note reports on the design, construction, and use of 
an innovative phantom developed for advanced imaging technologies                       
(e.g. multi-detector CT and the numerous applications of flat-panel detectors in                
dual-energy imaging, tomosynthesis, and cone-beam CT) in diagnostic and image 
guided procedures. The design addresses shortcomings of existing phantoms                       
